Opioid Dependence Leads To ‘Tsunami’ Of Medical Services, Study Finds
(By Julie Appleby for Kaiser Health News) In one of the first looks at privately insured patients with opioid problems,
Read More
Part D/Prescription Drugs
Alzheimer’s researchers seethe over years of missteps after latest drug failure
(By Sharon Begley for STAT) In the wake of disappointing results this week for yet another experimental Alzheimer’s drug, scientists who
Read MorePoison control centers are getting a surge of calls about ‘natural’ painkiller kratom
(By Eric Boodman for STAT) The herbal supplement seemed like a miracle. Trying to kick an opioid addiction, the middle-aged
Read MoreAt the DNC, the debate over drug prices gives way to charcuterie and cheese
(By Dylan Scott for STAT) PHILADELPHIA — The drug industry didn’t really feel the heat here at the Democratic National
Read MoreGilead hep C drug prices blamed for England’s health service rationing treatment
(By Ed Silverman for STAT) Faced with budgetary constraints, England’s National Health Service took several controversial steps to delay coverage
Read MoreThe best drug to fight Zika may already be approved and out there, study suggests
(By Andrew Joseph for STAT) Several teams of scientists are racing to develop a vaccine for the Zika virus. But
Read MoreIs Your Dr. an Implanter, Prescriber or Both?
The Food and Drug Administration approved Probuphine (used in treatment of drug additions) under the condition that physicians are trained
Read MoreWhat is Carb-X?
Combating antibiotic Resistant Bacteria Biopharmaceutical Accelerator or Carb-X for short is bringing together the United States and British health officials,
Read MoreThis smells promising: Nasal bacteria pump out a new antibiotic that kills MRSA
(By Anna Vlasits for STAT) Humans, and the microbes that live inside us, could be the source of the next
Read MorePromising Alzheimer’s treatment flops in new trial, crushing hopes
(By Damian Garde for STAT) A closely watched treatment for Alzheimer’s disease came up short in a late-stage trial, marking the
Read More